BACKGROUND: Assay of methylenetetrahydrofolate reductase (MTHFR), a key enzyme in homocysteine metabolism, is important for the study of severe and mild deficiency states. Because the conventional assay measures in the reverse direction, lacks sensitivity, and uses nonphysiologic substrates, the exact measurement and characterization of residual activity in easily accessible tissues have been difficult. METHODS: To measure MTHFR in the physiologic direction, we determined the NADPH-dependent conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate by use of HPLC with fluorescence detection. RESULTS: MTHFR activity in control fibroblast in the presence of FAD was maximal between pH 6.3 and 6.9, increased linearly up to 40 min and 80 microg protein/assay, and showed K(m)s of 30 micromol/L for NADPH and 26 micromol/L for 5,10-methylenetetrahydrofolate. Intraassay variation (CV) was 10%, interassay variation was 7.2%, and variation among 10 subcultures of the same cell line was 18%. Mean (SD) control activity was 431 (150) microU/mg protein (range, 242-910; n = 75), which is 2.5-fold higher than that with the reverse assay. After heat treatment (46 degrees C for 5 min), the activity showed a trimodal distribution corresponding to the 677TT (thermolabile; 15%), 677CT (35%), and 677CC (51%) genotypes. We found clearly measurable activity ranging from 2.6% to 25.6% of the mean control value in 15 patients with MTHFR deficiency, including 11 cell lines with zero activity in the reverse assay. Ten patients had complete enzyme deficiency. CONCLUSION: This assay allows reliable determination of residual activity in mutant fibroblasts and characterization of kinetic parameters for natural substrates.
BACKGROUND: Assay of methylenetetrahydrofolate reductase (MTHFR), a key enzyme in homocysteine metabolism, is important for the study of severe and mild deficiency states. Because the conventional assay measures in the reverse direction, lacks sensitivity, and uses nonphysiologic substrates, the exact measurement and characterization of residual activity in easily accessible tissues have been difficult. METHODS: To measure MTHFR in the physiologic direction, we determined the NADPH-dependent conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate by use of HPLC with fluorescence detection. RESULTS:MTHFR activity in control fibroblast in the presence of FAD was maximal between pH 6.3 and 6.9, increased linearly up to 40 min and 80 microg protein/assay, and showed K(m)s of 30 micromol/L for NADPH and 26 micromol/L for 5,10-methylenetetrahydrofolate. Intraassay variation (CV) was 10%, interassay variation was 7.2%, and variation among 10 subcultures of the same cell line was 18%. Mean (SD) control activity was 431 (150) microU/mg protein (range, 242-910; n = 75), which is 2.5-fold higher than that with the reverse assay. After heat treatment (46 degrees C for 5 min), the activity showed a trimodal distribution corresponding to the 677TT (thermolabile; 15%), 677CT (35%), and 677CC (51%) genotypes. We found clearly measurable activity ranging from 2.6% to 25.6% of the mean control value in 15 patients with MTHFR deficiency, including 11 cell lines with zero activity in the reverse assay. Ten patients had complete enzyme deficiency. CONCLUSION: This assay allows reliable determination of residual activity in mutant fibroblasts and characterization of kinetic parameters for natural substrates.
Authors: P Burda; A Kuster; O Hjalmarson; T Suormala; C Bürer; S Lutz; G Roussey; L Christa; J Asin-Cayuela; G Kollberg; B A Andersson; D Watkins; D S Rosenblatt; B Fowler; E Holme; D S Froese; M R Baumgartner Journal: J Inherit Metab Dis Date: 2015-01-30 Impact factor: 4.982
Authors: Francesco E Boccalatte; Claudia Voena; Chiara Riganti; Amalia Bosia; Lucia D'Amico; Ludovica Riera; Mangeng Cheng; Bruce Ruggeri; Ole N Jensen; Valerie L Goss; Kimberly Lee; Julie Nardone; John Rush; Roberto D Polakiewicz; Michael J Comb; Roberto Chiarle; Giorgio Inghirami Journal: Blood Date: 2008-10-09 Impact factor: 22.113
Authors: Martina Huemer; Regina Mulder-Bleile; Patricie Burda; D Sean Froese; Terttu Suormala; Bruria Ben Zeev; Patrick F Chinnery; Carlo Dionisi-Vici; Dries Dobbelaere; Gülden Gökcay; Mübeccel Demirkol; Johannes Häberle; Alexander Lossos; Eugen Mengel; Andrew A Morris; Klary E Niezen-Koning; Barbara Plecko; Rossella Parini; Dariusz Rokicki; Manuel Schiff; Mareike Schimmel; Adrian C Sewell; Wolfgang Sperl; Ute Spiekerkoetter; Beat Steinmann; Grazia Taddeucci; Jose M Trejo-Gabriel-Galán; Friedrich Trefz; Megumi Tsuji; María Antònia Vilaseca; Jürgen-Christoph von Kleist-Retzow; Valerie Walker; Jiri Zeman; Matthias R Baumgartner; Brian Fowler Journal: J Inherit Metab Dis Date: 2015-05-30 Impact factor: 4.982
Authors: Martina Huemer; Daria Diodato; Bernd Schwahn; Manuel Schiff; Anabela Bandeira; Jean-Francois Benoist; Alberto Burlina; Roberto Cerone; Maria L Couce; Angeles Garcia-Cazorla; Giancarlo la Marca; Elisabetta Pasquini; Laura Vilarinho; James D Weisfeld-Adams; Viktor Kožich; Henk Blom; Matthias R Baumgartner; Carlo Dionisi-Vici Journal: J Inherit Metab Dis Date: 2016-11-30 Impact factor: 4.982
Authors: Gustavo A Bezerra; Alexander Holenstein; William R Foster; Bing Xie; Kevin G Hicks; Céline Bürer; Seraina Lutz; Ayan Mukherjee; Dipika Sarkar; Debomita Bhattacharya; Jared Rutter; Arindam Talukdar; Peter J Brown; Minkui Luo; Lei Shi; D Sean Froese; Wyatt W Yue Journal: Biochimie Date: 2021-01-18 Impact factor: 4.079
Authors: Jochen Weile; Nishka Kishore; Song Sun; Ranim Maaieh; Marta Verby; Roujia Li; Iosifina Fotiadou; Julia Kitaygorodsky; Yingzhou Wu; Alexander Holenstein; Céline Bürer; Linnea Blomgren; Shan Yang; Robert Nussbaum; Rima Rozen; David Watkins; Marinella Gebbia; Viktor Kozich; Michael Garton; D Sean Froese; Frederick P Roth Journal: Am J Hum Genet Date: 2021-07-01 Impact factor: 11.025